ARMISTICE CAPITAL, LLC - 31 Mar 2025 SCHEDULE 13G/A Report for Quoin Pharmaceuticals, Ltd. American Depositary Shares, each representing one (1) Ordinary Shares, no par value per share QNRX The Nasdaq Stock Market LLC Ordinary S (QNRX)

Filing Manager
ARMISTICE CAPITAL, LLC
Reporting Manager
Armistice Capital, LLC
Security
Quoin Pharmaceuticals, Ltd. American Depositary Shares, each representing one (1) Ordinary Shares, no par value per share QNRX The Nasdaq Stock Market LLC Ordinary S
Symbol
QNRX
Shares outstanding
21,666,994 shares
Disclosed Ownership
1,081,183 shares
Ownership
5%
Form type
SCHEDULE 13G/A
Filing time
15 May 2025, 15:40:05 UTC
Date of event
31 Mar 2025
SEC
View on sec.gov

Sponsored

Quoteable Key Fact

"ARMISTICE CAPITAL, LLC disclosed 5% ownership in Quoin Pharmaceuticals, Ltd. American Depositary Shares, each representing one (1) Ordinary Shares, no par value per share QNRX The Nasdaq Stock Market LLC Ordinary S (QNRX) on 31 Mar 2025."

Quick Takeaways

  • ARMISTICE CAPITAL, LLC filed SCHEDULE 13G/A for Quoin Pharmaceuticals, Ltd. American Depositary Shares, each representing one (1) Ordinary Shares, no par value per share QNRX The Nasdaq Stock Market LLC Ordinary S (QNRX).
  • Disclosed ownership: 5%.
  • Date of event: 31 Mar 2025.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 15 May 2025, 15:40.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Official SEC Source

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (2)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Armistice Capital, LLC 5% 1,081,183 0 1,081,183 /s/ Steven Boyd Steven Boyd - Managing Member
Steven Boyd 5% 1,081,183 0 1,081,183 /s/ Steven Boyd Steven Boyd

Sponsored